Severe obstetric bleeding treated with recombinant activated factor VII (rFVIIa)

被引：0

作者：

Segal, S ^{[1
]}

Shemesh, IY ^{[1
]}

Blumental, R ^{[1
]}

Yoffe, B ^{[1
]}

Laufer, N ^{[1
]}

Ezra, Y ^{[1
]}

Levy, I ^{[1
]}

Mazor, M ^{[1
]}

Martinowitz, U ^{[1
]}

机构：

[1] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel

来源：

2ND WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY | 2001年

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Recombinant activated factor VII (rFVIIa; NovoSeven(R)) was successfully used in 3 patients with massive obstetric hemorrhage caused by placenta previa accreta, rupture of the uterine wall and preeclampsia complicated by HELLP syndrome. rFVIIa was administered intravenously to the 3 patients after all hemostatic attempts failed, they were critically ill multi-transfused and close to exsanguination. In one patient this treatment was life-saving and in the other two it helped to control the bleeding. rFVIIa is a promising new agent for hemorrhage control in massive obstetric bleeding.

引用

页码：43 / 46

页数：4

共 50 条

[1] Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)
S. Segal
I. Y. Shemesh
R. Blumenthal
B. Yoffe
N. Laufer
Y. Ezra
I. Levy
M. Mazor
U. Martinowitz
[J]. Archives of Gynecology and Obstetrics, 2003, 268 (4) : 266 - 267
[2] Control of a persistent obstetric haemorrhage with activated recombinant factor VII (rFVIIA)
Jakobsen, DJ
Shemesh, IY
Boksenbojm, PM
Blumenntal, R
Segal, S
Yoffe, B
Martinovitz, U
[J]. INTENSIVE CARE MEDICINE, 2001, 27 : S173 - S173
[3] Activated recombinant factor VII (rFVIIa)
Grottke, Oliver
Henzler, Dietrich
Rossaint, Rolf
[J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2010, 24 (01) : 95 - 106
[4] Recombinant activated factor VII (rFVIIa) in the treatment of 13 patients with severe and active bleeding esophageal varices
Romero-Castro, R
Pellicer-Bautista, F
Jimenez-Saenz, M
Gomez-Parra, M
Sendon-Perez, A
Guerrero-Aznar, MD
Herrerias-Gutierrez, JM
[J]. GASTROENTEROLOGY, 2004, 126 (04) : A386 - A386
[5] Recombinant activated factor VII (rFVIIa) in the treatment of seven cases of severe and active bleeding esophageal varices
Romero, R
Pellicer, F
Jimenez, M
Gomez, M
Guerrero, MD
Sendon, A
Herrerias, JM
[J]. GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB143 - AB143
[6] Recombinant activated factor VII in the management of massive obstetric bleeding
Palomino, MAP
Chaparro, MJS
De Elvira, MJZR
Curiel, EB
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (03) : 226 - 227
[7] Pharmacokinetics of recombinant activated factor VII (rFVIIa)
Erhardtsen, E
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 385 - 391
[8] Hemostasis in severe postpartum hemorrhage - The effect of recombinant activated factor VII (RFVIIA)
Segal, S
Shemesh, IY
Yoffe, B
Laufer, N
Mankuta, D
Mazor, M
Zohar, S
Shiff, E
Ben-Tal, O
Pauzner, D
Martinowitz, U
[J]. THROMBOSIS RESEARCH, 2005, 115 : 141 - 141
[9] Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Baudo, F
Gaidano, G
Carloni, MT
Coppola, A
Fariciotti, A
Iorio, A
Marietta, M
Marongiu, F
Mazzucconi, MG
Miraglia, E
Schiavoni, M
Schinco, PC
[J]. BLOOD, 2002, 100 (11) : 100B - 100B
[10] Use of recombinant activated factor VII (rFVIIa) in pediatric patients with high bleeding risk
Sciuccati, C.
Hepner, M.
Torres, A. Feliu
Pieroni, G.
Gomez, J. Avalos
Bonduel, M.
[J]. HAEMOPHILIA, 2010, 16 : 115 - 115

← 1 2 3 4 5 →